AVR Stock Discussion

Anteris Technologies Ltd Description

Anteris Technologies Ltd operates as a structural heart company. The company offers ADAPT technology, which re-engineers xenograft tissue into a pure collagen scaffold; and develops DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. It also researches and develops regenerative medicine and immunotherapies. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Medical Specialties Regenerative Medicine Anatomy Aortic Stenosis Valvular Heart Disease